Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with several more in development. Aitia’s partners include seven of the top ten pharmaceutical companies, leading academic research and medical centers, medical societies, leading multi-omic data companies, and patient advocacy groups globally.
| Website | http://www.aitiabio.com |
| Employees | 132 (0 on RocketReach) |
| Founded | 2000 |
| Address | 561 Windsor St, Somerville, Massachusetts 02143, US |
| Phone | +1 617-374-2300 |
| Industry | Biotechnology Research |
| Keywords | Drug Discovery, Ai Driven Drug Discovery, Causal Ai, Drug Development, Precision Medicine, Computational Biology, Multi Omics, Biotechnology, Pharmaceutical, Patient Data, Artificial Intelligence, Therapeutics, Machine Learning, High Performance Computing, Data Analysis, Big Data Analytics, Clinical Trials |
| Competitors | Schrödinger, Insilico Medicine, Atomwise, Stratified Medical, CureMetrix, Recursion Pharmaceuticals, BioAge Labs, PathAI, GENOOX, BenchSci +28 more (view full list) |
Looking for a particular Aitia employee's phone or email?
Aitia Questions
Aitia is based in Somerville, Massachusetts.
Related Companies
